MUDr. Pavel Fabian, Ph.D.
Total number of publications: 139
2019
-
miR-376b-3p jako biomarker odpovědi na léčbu sunitinibem u pacientů s metastatickým karcinomem ledviny.
Year: 2019, type: Conference abstract
2018
-
Catechol-O-methyltransferase: a dual-role player in different breast cancer subtypes?
Year: 2018, type: Conference abstract
-
Dual role of catechol-O-methyltransferase in the context of breast cancer heterogeneity
Year: 2018, type: Conference abstract
2017
-
Adjustment of serum HE4 to reduced glomerular filtration and its use in biomarker-based prediction of deep myometrial invasion in endometrial cancer
Oncotarget, year: 2017, volume: 8, edition: 64, DOI
-
Intramammární uzlina u karcinomu prsu z pohledu chirurga
Year: 2017, type: Conference abstract
-
MicroRNAs as outcome predictors in patients with metastatic colorectal cancer treated with bevacizumab in combination with FOLFOX
Oncology letters, year: 2017, volume: 14, edition: 1, DOI
-
Panitumumab use in metastatic colorectal cancer and patterns of RAS testing: results from a Europe-wide physician survey and medical records review
BMC Cancer, year: 2017, volume: 17, edition: 798, DOI
2016
-
Decreased expression levels of PIWIL1, PIWIL2, and PIWIL4 are associated with worse survival in renal cell carcinoma patients
ONCOTARGETS AND THERAPY, year: 2016, volume: 9, edition: January, DOI
-
Dlouhodobá parciální remise metastatického inflamatorního myofibroblastického tumoru pankreatu po chemoterapii - kazuistika pacienta
Year: 2016
-
EPITHELIAL-MESENCHYMAL TRANSITION-ASSOCIATED MICRORNA/MRNA SIGNATURE IS LINKED TO METASTASIS AND PROGNOSIS IN CLEAR-CELL RENAL CELL CARCINOMA
Year: 2016, type: Conference abstract